R. K. Oldham
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 42
- CAR-T cell therapy research 11
- Cancer Immunotherapy and Biomarkers 8
- HER2/EGFR in Cancer Research 7
- Immunology 29
- Immunotherapy and Immune Responses 15
- Immune Cell Function and Interaction 12
- Co-authors
- F. Anthony GrecoRonald B. HerbermanPaul G. AbramsJ. L. McCoyR B HerbermanKenneth A. FoonA E MaluishRobert W. Schroff
- Journals
- JNCI Journal of the National Cancer Institute (9 papers)The Journal of Immunology (7 papers)Cancer Immunology Immunotherapy (6 papers)Journal of Clinical Oncology (5 papers)Cellular Immunology (3 papers)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
R. K. Oldham
74 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 101
- Immunology 892
- Oncology 869
- Radiology, Nuclear Medicine and Imaging 543
- Biotechnology 127
- Genetics 112
Countries citing papers authored by R. K. Oldham
This map shows the geographic impact of R. K. Oldham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. K. Oldham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. K. Oldham more than expected).
Fields of papers citing papers by R. K. Oldham
This network shows the impact of papers produced by R. K. Oldham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. K. Oldham. The network helps show where R. K. Oldham may publish in the future.
Co-authors
The 25 scholars most cited alongside R. K. Oldham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 30 | |
| 2 | Cancer biotherapy with interferon, interleukin-2 and tumor-derived activated cells (TDAC). | 1995 | 3 |
| 3 | 1991 | 87 | |
| 4 | 1990 | 6 | |
| 5 | 1990 | 51 | |
| 6 | Therapeutic murine monoclonal antibodies developed for individual cancer patients. | 1989 | 4 |
| 7 | 1989 | 18 | |
| 8 | 1989 | 25 | |
| 9 | 1989 | 5 | |
| 10 | 1988 | 5 | |
| 11 | Poorly differentiated neoplasms and tumors of unknown origin | 1986 | 20 |
| 12 | 1985 | 43 | |
| 13 | 1982 | 1 | |
| 14 | 1981 | 8 | |
| 15 | Phase II trial of piperazinedione in malignant melanoma: a report by the Southeastern Cancer Study Group. | 1979 | 1 |
| 16 | 1978 | 33 | |
| 17 | Immunologic aspects of small cell carcinoma. | 1978 | 7 |
| 18 | 1978 | 2 | |
| 19 | 1977 | 10 | |
| 20 | 1976 | 11 |
About R. K. Oldham
R. K. Oldham is a scholar working on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Biotechnology and Pathology and Forensic Medicine, having authored 77 papers that have together received 2.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (21 papers), Immunotherapy and Immune Responses (15 papers), Immune Cell Function and Interaction (12 papers), CAR-T cell therapy research (11 papers), Lymphoma Diagnosis and Treatment (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), HER2/EGFR in Cancer Research (7 papers) and Lung Cancer Treatments and Mutations (7 papers). The work is most often cited by research in Immunology (892 citations), Oncology (869 citations), Radiology, Nuclear Medicine and Imaging (543 citations), Biotechnology (127 citations) and Genetics (112 citations). R. K. Oldham has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include F. Anthony Greco, Ronald B. Herberman, Paul G. Abrams, J. L. McCoy, R B Herberman, Kenneth A. Foon, A E Maluish, Robert W. Schroff, Robert Birch and A C Morgan. Their work appears in journals such as JNCI Journal of the National Cancer Institute, The Journal of Immunology, Cancer Immunology Immunotherapy, Journal of Clinical Oncology and Cellular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.